Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Precision Medicine for All?: What About Hypertrophic Cardiomyopathy?
A Discussion of Contemporary Nomenclature, Diagnosis, Imaging, and Management of Patients With Hypertrophic Cardiomyopathy.
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.
The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
Risk Stratification in Hypertrophic Cardiomyopathy: Highly Effective, But Could It Be Better?
See All 12 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Risk Stratification in Hypertrophic Cardiomyopathy: Highly Effective, But Could It Be Better?
Maron MS. Risk Stratification in Hypertrophic Cardiomyopathy: Highly Effective, But Could It Be Better? Circ Cardiovasc Imaging. 2017 07; 10(7).
View in:
PubMed
subject areas
Cardiomyopathy, Hypertrophic
Death, Sudden, Cardiac
Humans
Prognosis
authors with profiles
Martin S Maron MD, MSPH